Imagion’s breakthrough cancer device in manufacturing milestone

Australian listed medical imaging company Imagion Biosystems has moved a step closer to trialing its breakthrough cancer detection device, with the first phase of manufacture of a nanoparticle formulation completed despite the Covid-19 pandemic. Manufacture of the company’s MagSense HER2 nanoparticle formulation proceeded uninterrupted by the pandemic under good manufacturing practice (GMP) conditions. The second…

Patent system review launched

Industry minister Karen Andrews has announced that a patent system review will be launched some time in the next few months and be delivered to the federal government by May 2021. The review would run for six months, be chaired by Emeritus Professor Raoul Mortley, and “consider the accessibility for small and medium enterprises (SMEs)”. It…